Health

The latest developments affecting patients and practitioners

Health

Many breast cancer patients can skip chemo, big study finds

By Associated Press

Stem Cell Storage
Health

Stem cell bank opens with backing from leading scientists. Is it worth the money?

By Andrew Joseph

Gabapentinoids Abuse
Politics

FDA officials warn about the ‘next wave’ of drug abuse: opioid substitutes

By Lev Facher

Jim Ewing 04
In the Lab

Pioneering surgery makes a prosthetic foot feel like the real thing

By Gideon Gil and Matthew Orr

Human Colon Cancer Cells
Health

Cancer group says colon screening should start at 45, not 50

By Associated Press

Ebola Vaccines
Health

Ebola outbreak opens way to chaotic jockeying to test experimental drugs

By Helen Branswell

Birth Control Recall
Health

Allergan recalls birth-control pill packs with out-of-order placebos

By Elizabeth Cooney

Multiple Myeloma 01
Health

Once quickly lethal and still humbling, multiple myeloma may be in a ‘golden age’ of treatment

By Karen Weintraub

Schizophrenia Pregnancy
Health

Schizophrenia ‘risk genes’ are not so risky if the mother’s pregnancy was healthy

By Sharon Begley

Health

Vaccinations set to begin in Ebola outbreak epicenter

By Helen Branswell

Polio Stool Samples
Health

Polio eradication initiative meets resistance to appeals to destroy samples

By Helen Branswell

Artificial intelligence FDA
Politics

Artificial intelligence is evolving fast. Can the FDA keep up?

By Casey Ross

Norman Sharpless
Health

The head of the National Cancer Institute on hopes for AI, the future of precision medicine, and big data

By Lev Facher

Stream
Pharmalot

Pharmaceutical manufacturing plants are sending lots of medicine into the water supply

By Ed Silverman

Antibiotics IV
Politics

Effort to encourage development of new antibiotics falls short in Senate

By Ike Swetlitz

Mbandaka Ebola vaccination
Health

Excitement over use of Ebola vaccine in outbreak tempered by real-world challenges

By Helen Branswell

VC Health Boot Camp
Health

A new VC firm will invest in your startup — and pay for you to get therapy and acupuncture

By Rebecca Robbins

FDA Gene Therapy
Biotech

FDA plans to speed path to approval for some gene therapies, starting with hemophilia

By Ike Swetlitz

Kevin McCarthy Speaks
Health

Congress passes ‘right-to-try’ measure, sending hard-fought bill to Trump’s desk

By Erin Mershon

Lisa Hensley
Health

‘You’re holding your breath’: Scientists who toiled for years on an Ebola vaccine see the first one put to the test

By Helen Branswell

Health

Ebola outbreak is concerning, but falls short of global emergency, WHO panel says

By Helen Branswell

Doctor Recording
Health

More patients are taking home recordings of their doctor visits. But who else could listen?

By Casey Ross

Amgen
Biotech

Amgen’s new migraine drug will cost 30 percent less than Wall Street expected

By Damian Garde

Francis Collins
Politics

After controversy over industry funding, NIH halts enrollment in moderate drinking study

By Andrew Joseph

Medical Form
In the Lab

Researchers mine emergency contacts to discover genetic clues to disease

By Elizabeth Cooney

WHO Ebola Response
Health

WHO to weigh declaration of international emergency over Ebola outbreak

By Helen Branswell

Jack Hogan Eye Exam
Biotech

After nerve-wracking eye surgery, the world comes into focus for early gene therapy recipient

By Eric Boodman

Opioid Withdrawal
Health

In a first, FDA approves drug meant to mitigate symptoms of opioid withdrawal

By Lev Facher

WHO Ebola Bikoro
Health

As Ebola flares once again, a rapid global response invites cautious hope

By Helen Branswell

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.

Privacy Policy